HAFNIA ALVEI FORMULATIONS
A composition essentially made of a Hafnia alvei probiotic strain expressing the ClpB protein; wherein the ClpB protein is in an amount of at least 0.7% (w/w) in weight relative to the total weight of the composition; and the ratio of the total number of Hafnia alvei Colony Forming Units to the tota...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
06.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A composition essentially made of a Hafnia alvei probiotic strain expressing the ClpB protein; wherein the ClpB protein is in an amount of at least 0.7% (w/w) in weight relative to the total weight of the composition; and the ratio of the total number of Hafnia alvei Colony Forming Units to the total Hafnia alvei cell number ranges from 10−4 to 0.8. Also, oral dosage forms, namely gastro-resistant capsules including the composition of essentially made of a Hafnia alvei probiotic strain expressing the ClpB protein. |
---|---|
Bibliography: | Application Number: EP20190842780 |